Clinical Trial Results Home

Hypertension

 Contents
Background
Trials
 Background

JNC Guidelines

      -National High Blood Pressure Education Program Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI)

Renovascular Hypertension and Renal Artery Ultrasounds

      -by Dr. Amjad AlMahameed

Severe Hypertension

      -Disease State Awareness, Treatment Options, and Cleviprex (clevidipine butyrate) Background

(Return to Contents)

 Trials

Aliskiren and Valsartan for Antihypertensive Therapy Trial

      -Trial Overview by Dr. Suzanne Oparil (ACC 2007)

ALLHAT: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

      -Trial Overview (2002)

ECLIPSE: The Evaluation of CLevidipine In the Perioperative Treatment of Hypertension Assessing Safety Events trial

      -Blood Pressure Control is an Independent Predictor of Short-term Mortality in Cardiac Surgery Patients: Analysis from the Three Randomized ECLIPSE Trials by Dr. Solomon Aronson

      -Blood Pressure Control with Clevidipine Compared with Nitroglycerin, Sodium Nitroprusside, or Nicardipine in the Treatment of Peri-operative Hypertension: Results of the Three Randomized ECLIPSE Trials by Dr. Solomon Aronson

ESCAPE: Evaluation Study Of Congestive Heart Failure And Pulmonary Artery Catheterization Effectiveness

      -ESCAPE-1: Pre-operative (2007); ESCAPE 2: Post-operative (2008) Clevidipine Phase III Studies: Perioperative Hypertension

IMAGINE: Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme

      -Trial Overview by Dr. W H van Gilst(ESC 2005)

INVEST: International Verapamil SR - Trandolapril Study

      -Main Outcomes, Predictors of Risk, Diabetes, New Diabetes, BP and Depression/QOL Sub-analyses by Dr. Carl J. Pepine

LIFE: Losartan Intervention For Endpoint reduction in hypertension study

      -ACC 2002 Scientific Session Presentation by Dr. Bjorn Dahlof

      -Major Clinical Endpoints in Patients With and Without Isolated Systolic Hypertension

 

NAGOYA HEART Study: Comparison between Valsartan and Amlodipine Regarding Cardiovascular Morbidity and Mortality in Hypertensive Patients with Glucose Intolerance

      -Trial Overview by Dr. Toyoaki Murohara (ACC 2011)

 

OSCAR: The Comparison of High-Dose Angiotensin II Receptor Blocker (ARB) Monotherapy versus Combination Therapy of ARB with Calcium Channel Blocker on Cardiovascular Events in Japanese Elderly High-Risk Hypertensive Patients

      -Trial Overview by Dr. Hisao Ogawa (ACC 2011)

VELOCITY: Evaluation of the Effect of Ultra-Short-Acting Clevidipine In the Treatment of Patients With Severe Hypertension

      -Prolonged Infusion of Clevidipine Results in Safe and Predictable Blood Pressure Control in Patients with Acute Severe Hypertension by Dr. J. Varon (2004)

(Return to Contents)

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster